Utama › Karsinoma Duktal In Situ (DCIS) › Florida
Kajian klinikal Karsinoma Duktal In Situ (DCIS) di Florida
7 kajian untuk Karsinoma Duktal In Situ (DCIS) sedang mencari peserta di lokasi di Florida.
Bandar di Florida
Teks kajian rasmi (Bahasa Inggeris)
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
- Moffitt Cancer Center, Tampa
Mengambil pesertaFasa 2
Umur 18 ke atas · Wanita · Dikemas kini 28 Sep 2026 · NCT06075953Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- TopLine MD Alliance, Miami
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 30 hingga 74 · Wanita · Dikemas kini 21 Sep 2026 · NCT02620852Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
- Baptist Alliance Miami Cancer Institute, Miami
Mengambil pesertaFasa 2
Umur 45 ke atas · Wanita · Dikemas kini 21 Sep 2026 · NCT04084730Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisions
- University of Florida, Gainesville
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06903468The PREDICT Registry:
- Baptist MD Anderson Cancer Center, Jacksonville
- BayCare Health System, Tampa
- University of South Florida, Tampa
Mengambil pesertaKajian pemerhatian
Umur 30 hingga 85 · Wanita · Dikemas kini 17 Apr 2026 · NCT03448926A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- Mayo Clinic in Florida, Jacksonville
Mengambil pesertaFasa 1
Umur 18 ke atas · Wanita · Dikemas kini 5 Mac 2026 · NCT04144023Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT)
- CyberKnife Center of South Florida in Stuart, Stuart
- CyberKnife Centers of Tampa Bay, Tampa
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 50 hingga 100 · Wanita · Dikemas kini 5 Ogo 2022 · NCT04985032Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.